Evidence-based medicine: botulinum toxin A in migraine and tension-type headache

Citation
H. Gobel et al., Evidence-based medicine: botulinum toxin A in migraine and tension-type headache, J NEUROL, 248, 2001, pp. S34-S38
Citations number
22
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROLOGY
ISSN journal
03405354 → ACNP
Volume
248
Year of publication
2001
Supplement
1
Pages
S34 - S38
Database
ISI
SICI code
0340-5354(200104)248:<S34:EMBTAI>2.0.ZU;2-C
Abstract
The therapeutic effect of botulinum toxin in headache was observed coincide ntally. The rationale for this new indication initially met with a great de al of scepticism, because the toxin's mechanism of action, cholinergic chem odenervation, does not fit the pathophysiological concept of migraine and o ther forms of headache. Meanwhile a fair number of studies have been publis hed which indicate efficacy for botulinum toxin and recommend its use for t he treatment of tension headache and migraine. According to the evidence-ba sed medicine criteria, grade I evidence has been demonstrated. In addition the use of botulinum toxin for cluster-headache and secondary headache is d iscussed. Further large scale studies will be regarded to demonstrate the long-term e fficacy.